

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">

<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Reprod Infert</journal-id>
      <journal-id journal-id-type="publisher-id">arij001</journal-id>
      <journal-title-group>
        <journal-title>Journal of Reproduction &amp; Infertility</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2228-5482</issn>
      <issn pub-type="epub">2251-676X</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">jri140159</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Prevalence of Polycystic Ovary Syndrome in Iranian Adolescent Girls Based on Adults and Adolescents’ Diagnostic Criteria in Mashhad City</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Pourhoseini</surname><given-names>Seyedeh Azam</given-names></name></contrib><aff>Department of Obstetrics and Gynecology, School of Medicine, Mashhad University of Medical Sciences, Mashad, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Babazadeh</surname><given-names>Raheleh</given-names></name></contrib><aff>Nursing and Midwifery Care Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Mazlom</surname><given-names>Seyed Reza</given-names></name></contrib><aff>Nursing and Midwifery Care Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</aff></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>23</volume>
      <issue>4</issue>
      <fpage>288</fpage>
      <lpage>296</lpage>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>9</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>2</month>
          <year>2022</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;Background: PCOS is a common endocrine disorder of reproductive age with high morbidity that its prevalence ranging from 5.6% to 26%. The aim of this study was to evaluate the prevalence of PCOS in Iranian adolescent girls aged 14-19 years based on adults and adolescents&amp;rsquo; criteria.&lt;br /&gt;
Methods: This cross-sectional study was carried out with 650 high school adolescent girls in Mashhad city, north-east of Iran. PCOS was defined as the presence of three or two of the three features including oligo/amenorrhea, clinical or biochemical hyperandrogenism, and polycystic ovaries. Descriptive statistics, chi-square, and t-test were used to analyze the data through SPSS &lt;em&gt;vs &lt;/em&gt;22 (SPSS Inc., USA) and the significance level was set at p&amp;le;0.05.&lt;br /&gt;
Results: The mean age of adolescent girls was 16.73&amp;plusmn;3.4 years. The prevalence of PCOS using Rotterdam, National Institutes of Health (NIH), Androgen Excess&amp;ndash; PCOS Society (AES), European Society of Human Reproduction and Embryology (ESHRE)/American Society for Reproductive Medicine (ASRM) (2012), and Endocrine Society Clinical Practice (2013) criteria was 4.2%, 3.6%, 3.6%, 0.7%, and 3.6%, respectively.&lt;br /&gt;
Conclusion: The rate for prevalence of PCOS calculated based on Rotterdam, NIH, AES, and Endocrine Society (2013) criteria was higher in comparison to ESHRE/ ASRM (2012) criteria. According to the results of our study, in order to prevent overestimation of this syndrome&amp;rsquo;s prevalence in the adolescents due to its overlap with signs of pubertal development, all above-mentioned three criteria should be considered together, which is in line with the recommendations proposed by Carmina et al. and ESHRE/ASRM working group.&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>

    
</article>

